ES2084181T3 - Composiciones farmaceuticas para usar en el tratamiento del sida. - Google Patents

Composiciones farmaceuticas para usar en el tratamiento del sida.

Info

Publication number
ES2084181T3
ES2084181T3 ES91917237T ES91917237T ES2084181T3 ES 2084181 T3 ES2084181 T3 ES 2084181T3 ES 91917237 T ES91917237 T ES 91917237T ES 91917237 T ES91917237 T ES 91917237T ES 2084181 T3 ES2084181 T3 ES 2084181T3
Authority
ES
Spain
Prior art keywords
image
pharmaceutical compositions
aids
treatment
bri
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91917237T
Other languages
English (en)
Inventor
Stanislaw R Burzynski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2084181T3 publication Critical patent/ES2084181T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A LAS COMPOSICIONES FARMACEUTICAS PARA UTILIZAR EN EL TRATAMIENTO DE ENFERMEDADES ASOCIADAS AL SIDA ADMINISTRANDO AL HUESPED AFECTADO COMPOSICIONES FARMACEUTICAS QUE CONTIENEN UNA CANTIDAD EFECTIVA TERAPEUTICA DE PIPERIDINEDIONA SUSTITUIDA DE FORMULAS (I), (II) O (III), O MEZCLAS DE ESTAS, DONDE R ES OH, NH SUB 2, OW, O H; X ES H, F, CL, BR, I, OH, OW, GRUPO ALIFATICO C SUB 1 A C SUB 2; Z ES UN GRUPO ALIFATICO O AROMATICO DE C SUB 1 A C SUB 2; X E Y PUEDEN AMBOS VARIAR DENTRO DEL COMPUESTO; Y SALES FARMACEUTICAMENTE ACEPTABLES DE ESTAS . LAS COMPOSICIONES FARMACEUTICAS PUEDEN TAMBIEN COMPRENDER ACIDO FENILACETICO SUSTITUIDO DE R, X, Y.
ES91917237T 1990-09-04 1991-08-21 Composiciones farmaceuticas para usar en el tratamiento del sida. Expired - Lifetime ES2084181T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/577,464 US5089508A (en) 1990-09-04 1990-09-04 Methods for treating aids

Publications (1)

Publication Number Publication Date
ES2084181T3 true ES2084181T3 (es) 1996-05-01

Family

ID=24308852

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91917237T Expired - Lifetime ES2084181T3 (es) 1990-09-04 1991-08-21 Composiciones farmaceuticas para usar en el tratamiento del sida.

Country Status (11)

Country Link
US (1) US5089508A (es)
EP (1) EP0500905B1 (es)
AT (1) ATE135217T1 (es)
AU (1) AU638869B2 (es)
DE (1) DE69117923T2 (es)
DK (1) DK0500905T3 (es)
ES (1) ES2084181T3 (es)
GR (1) GR3019970T3 (es)
SG (1) SG81889A1 (es)
WO (1) WO1992004027A1 (es)
ZA (1) ZA916977B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5244922A (en) * 1990-09-04 1993-09-14 Burzynski Stanislaw R Methods for treating viral infections
EP0527241B1 (de) * 1991-07-15 1994-03-16 Artesan Pharma Gesellschaft mit beschränkter Haftung Verwendung der Ascorbinsäure zur Zubereitung von Arzneimitteln zur Anwendung im Genitalbereich
US5646182A (en) * 1992-06-15 1997-07-08 Burzynski; Stanislaw R. Methods for treating autoimmune diseases
ATE310505T1 (de) * 1996-05-14 2005-12-15 Stanislaw R Burzynski Liposomale antineoplaston therapie mit bemerkenswert verbesserter antineoplastischer aktivität
US6127419A (en) * 1998-11-23 2000-10-03 Burzynski; Stanislaw R. Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470970A (en) * 1981-07-02 1984-09-11 Burzynski Stanislaw R Purified antineoplaston fractions and methods of treating neoplastic disease
US4558057A (en) * 1981-12-15 1985-12-10 Burzynski Stanislaw R Purified antineoplaston fractions and methods of treating neoplastic disease
US4427684A (en) * 1982-09-24 1984-01-24 Ores Richard O Treatment and prevention of infection with herpes simplex and related viruses
DE3650733T2 (de) * 1985-09-11 2000-05-04 Btg Int Ltd Pharmazeutische Zubereitungen und medizinische Verwendungen von Dioxopiperidinderivaten, insbesondere als Verstärker der Immunantwort sowie als antivirale und antibakterielle Wirkstoffe
US4705796A (en) * 1986-08-25 1987-11-10 Stereochemical Genetics, Inc. Use of 3-N-phenylacetylamino-2,6-piperidinedione for treatment of neuropsychiatric disorders
DE3814549A1 (de) * 1987-10-30 1989-05-18 Bayer Ag N-substituierte derivate von 1-desoxynojirimycin und 1-desoxymannonojirimycin, verfahren zu deren herstellung und deren verwendung in arzneimitteln

Also Published As

Publication number Publication date
GR3019970T3 (en) 1996-08-31
ATE135217T1 (de) 1996-03-15
DK0500905T3 (da) 1996-08-05
EP0500905B1 (en) 1996-03-13
US5089508A (en) 1992-02-18
DE69117923D1 (de) 1996-04-18
AU638869B2 (en) 1993-07-08
AU8539791A (en) 1992-03-30
ZA916977B (en) 1992-06-24
WO1992004027A1 (en) 1992-03-19
SG81889A1 (en) 2001-07-24
DE69117923T2 (de) 1996-08-01
EP0500905A1 (en) 1992-09-02

Similar Documents

Publication Publication Date Title
ES2165969T3 (es) Compuestos nitrogenados aromaticos condensados 5,5 aril-sustituidos como agentes antiinflamatorios.
HUP0401192A2 (hu) Fényérzékenyítő szer alkalmazása sebek kezelésére adható gyógyászati készítmény előállítására
ES2139638T3 (es) 1,4-piperazinas disustituidas para el tratamiento de las enfermedades del sistema nervioso central y de las enfermedades neuroendocrinas.
ATE113834T1 (de) Zusammensetzung zur behandlung der schizophrenie.
AR009052A1 (es) Tienopirimidinas, un procedimiento para su preparacion, empleo de las mismas para preparar un medicamento, preparaciones farmaceuticas que lascontienen y un procedimiento para obtener estas preparaciones farmaceuticas
ATE231519T1 (de) Dinukleotide zur verwendung in der behandlung von lungenkrankheiten
ES2141957T3 (es) Uso de raloxifeno y sus analogos para la produccion de un medicamento para el tratamiento de enfermedades virales.
ATE188871T1 (de) Verfahren zur behandlung von viralen infectionen
ES2051834T3 (es) El uso de tetrahidrobenzeno(c,d)indol-6 carboxamidas para la preparacion de un medicamento para el tratamiento de la ansiedad.
ATE366107T1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
PT100415A (pt) Novas morfolinas de accao farmaceutica, e processo para a sua preparacao
IT1317048B1 (it) Uso dell'acido pamoico o di un suo derivato, o di un suo analogo, perla preparazione di un medicamento per il trattamento di patologie
ES2084181T3 (es) Composiciones farmaceuticas para usar en el tratamiento del sida.
NO304592B1 (no) Aminosyrer nyttige ved terapi av osteoartikulµre pÕvirkninger, farmas°ytiske blandinger og anvendelse derav
ES2104938T3 (es) Metodo de inhibir la fibrosis.
DE3786256T2 (de) Antifolat-mittel.
DE69206607T2 (de) Behandlung von kognitiven störungen.
SE9202218D0 (sv) Pharmacologically active alfa-(tertiary-aminomethyl)-benzenemethanol derivatives, pharmaceutical composition containing them, therapeutical use thereof and processes for their preparation
DE3275060D1 (en) Use of beta-(1-adamantyl)-alpha, alpha-dimethylethylamine for the manufacture of a medicament for the treatment of otitis externa in dogs
ES8307778A1 (es) Procedimiento para preparar difenilbutil-1-piperazinocarboxilatos.
DE3887611D1 (de) Butensäure-Amide, deren Salze, diese enthaltende pharmazeutische Zusammensetzungen und Verfahren zu deren Herstellung.
ES2005778A6 (es) Procedimiento para la obtencion de derivados de diisobutilxantina.
TH51768A (th) สารประกอบคาร์บาฟีเนม การใช้ของสารดังกล่าว และสารประกอบตัวกลางสำหรับสารดังกล่าว
MY110416A (en) Composition for the treatment of schizophrenia.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 500905

Country of ref document: ES